Indoco Remedies Croissance future
Future contrôle des critères 4/6
Indoco Remedies devrait augmenter ses bénéfices et son chiffre d'affaires de 72.2% et de 11.7% par an respectivement. Le BPA devrait croître de de 70.7% par an. Le rendement des capitaux propres devrait être 12.1% dans 3 ans.
Informations clés
72.2%
Taux de croissance des bénéfices
70.7%
Taux de croissance du BPA
| Pharmaceuticals croissance des bénéfices | 18.2% |
| Taux de croissance des recettes | 11.7% |
| Rendement futur des capitaux propres | 12.1% |
| Couverture par les analystes | Low |
| Dernière mise à jour | 26 Oct 2024 |
Mises à jour récentes de la croissance future
Indoco Remedies Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Oct 27
Recent updates
Indoco Remedies Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Oct 27Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders
May 24Earnings Miss: Indoco Remedies Limited Missed EPS By 56% And Analysts Are Revising Their Forecasts
Jan 26Does Indoco Remedies (NSE:INDOCO) Have A Healthy Balance Sheet?
Jan 26We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Indoco Remedies Limited's (NSE:INDOCO) CEO For Now
Sep 16Here's Why Indoco Remedies (NSE:INDOCO) Can Manage Its Debt Responsibly
May 21Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50
Aug 31Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50
Jul 04Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?
Jul 02Indoco Remedies (NSE:INDOCO) Seems To Use Debt Quite Sensibly
Jun 10Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?
Mar 25Indoco Remedies Limited's (NSE:INDOCO) Intrinsic Value Is Potentially 21% Below Its Share Price
Mar 09What Percentage Of Indoco Remedies Limited (NSE:INDOCO) Shares Do Insiders Own?
Feb 22Did You Miss Indoco Remedies' (NSE:INDOCO) 37% Share Price Gain?
Feb 07Indoco Remedies Limited's (NSE:INDOCO) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 17Is Indoco Remedies (NSE:INDOCO) A Risky Investment?
Dec 27
Calculating The Intrinsic Value Of Indoco Remedies Limited (NSE:INDOCO)
Dec 06What Type Of Shareholders Own The Most Number of Indoco Remedies Limited (NSE:INDOCO) Shares?
Nov 14Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 3/31/2027 | 23,285 | 1,799 | 1,379 | 2,654 | 3 |
| 3/31/2026 | 20,523 | 1,239 | 470 | 2,102 | 5 |
| 3/31/2025 | 17,509 | 247 | -796 | 2,212 | 4 |
| 9/30/2024 | 17,732 | 321 | -3,076 | 2,220 | N/A |
| 6/30/2024 | 18,223 | 767 | N/A | N/A | N/A |
| 3/31/2024 | 18,173 | 985 | -2,706 | 1,567 | N/A |
| 12/31/2023 | 17,958 | 1,016 | N/A | N/A | N/A |
| 9/30/2023 | 17,356 | 1,134 | -911 | 1,442 | N/A |
| 6/30/2023 | 16,869 | 1,281 | N/A | N/A | N/A |
| 3/31/2023 | 16,686 | 1,423 | -284 | 1,788 | N/A |
| 12/31/2022 | 16,496 | 1,569 | N/A | N/A | N/A |
| 9/30/2022 | 16,084 | 1,617 | 85 | 1,703 | N/A |
| 6/30/2022 | 15,622 | 1,537 | N/A | N/A | N/A |
| 3/31/2022 | 15,408 | 1,548 | 485 | 1,738 | N/A |
| 12/31/2021 | 14,368 | 1,393 | N/A | N/A | N/A |
| 9/30/2021 | 14,110 | 1,317 | 257 | 1,391 | N/A |
| 6/30/2021 | 13,524 | 1,157 | N/A | N/A | N/A |
| 3/31/2021 | 12,415 | 930 | 54 | 822 | N/A |
| 12/31/2020 | 12,084 | 734 | N/A | N/A | N/A |
| 9/30/2020 | 11,654 | 571 | 387 | 931 | N/A |
| 6/30/2020 | 11,298 | 393 | N/A | N/A | N/A |
| 3/31/2020 | 11,066 | 241 | 644 | 1,228 | N/A |
| 12/31/2019 | 10,909 | 302 | N/A | N/A | N/A |
| 9/30/2019 | 10,640 | 264 | N/A | N/A | N/A |
| 6/30/2019 | 10,071 | 111 | N/A | N/A | N/A |
| 3/31/2019 | 9,684 | -29 | 352 | 1,321 | N/A |
| 3/31/2018 | 10,424 | 412 | N/A | 1,227 | N/A |
| 3/31/2017 | 10,968 | 771 | N/A | 886 | N/A |
| 3/31/2016 | 10,081 | 819 | N/A | 1,122 | N/A |
| 3/31/2015 | 8,570 | 828 | N/A | 1,090 | N/A |
| 3/31/2014 | 7,336 | 580 | N/A | 988 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de INDOCO ( 72.2% par an) est supérieure au taux d'épargne ( 6.7% ).
Bénéfices vs marché: Les bénéfices de INDOCO ( 72.2% par an) devraient croître plus rapidement que le marché Indian ( 18% par an).
Croissance élevée des bénéfices: Les bénéfices de INDOCO devraient augmenter de manière significative au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de INDOCO ( 11.7% par an) devrait croître plus rapidement que le marché Indian ( 10.2% par an).
Croissance élevée des revenus: Le chiffre d'affaires de INDOCO ( 11.7% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de INDOCO devrait être faible dans 3 ans ( 12.1 %).